Skyscape Web Viewer : Targeted Cancer Therapy A Handbook for Nurses : Main Index

View All
p21, turning on, HDAC inhibitors and
p38MAPK pathway Protein Kinase Signaling Pathways References (Chapter 2)
P450 isoenzyme pathways, important drug interactions between targeted therapies and
P450 microenzyme system Chapter 2. Targeted Cancer Therapy: External and Internal Signaling Pathway Targets drug interactions: focus on Drug Interactions: Focus On The P450 Microenzyme System Epigenetic Abnormalities (Dna Methyltransferase and Histone Deacetylase) Introduction Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Monoclonal Antibodies Nursing Considerations and Drug Information Protein Kinase Inhibitors References (Chapter 5) two phases of drug metabolism in
P53 activity Antiangiogenic Drug Therapy Application Of The Hallmarks Of Cancer Chapter 2. Targeted Cancer Therapy: External and Internal Signaling Pathway Targets Epigenetics Glossary Mitotic Kinase Inhibitors Protein Dynamics: Heat Shock Proteins and Ubiquitin - Proteasome Inhibitors Protein Kinase Signaling Pathways References (Chapter 3) src family kinases and Targeting Apoptosis
Pamidronate (Aredia) adverse reactions available as Bone Metastasis class contraindications dosage and administration indications mechanism of action nursing discussion pharmacokinetics Pharmacologic Management reconstitution and preparation warnings
Pancreatic cancer, EGFR overexpression in Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Monoclonal Antibodies
Panitumumab (Vectibix, ABX-EGF) adverse reactions available as black box warnings class dosage and administration drug interactions indications mechanism of action Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) nursing discussion pharmacokinetics reconstitution and preparation warnings
Papulopustular rash
Parathyroid hormone, breast cancer, bone metastasis and
Parathyroid hormone-related peptide Bone Metastasis References (Chapter 4)
PARP1 Application Of The Hallmarks Of Cancer Dna Repair Gene Mutations: Opportunities From Synthetic Lethality enzymes inhibitors References References (Chapter 4)
Partridge, A. H.
Patient behaviors, barriers to adherence and
Patients receiving targeted therapy challenges in caring for, 289-310 adherence to and persistence with oral anticancer therapy, 302-303 barriers to adherence and persistence, 303-305 important drug interactions between P450 isoenzyme pathways and targeted therapies, 291-301t P450 microenzyme system and, 289-291 successful strategies to support adherence and persistence with oral anticancer therapy Chapter 5. Challenges in Caring for Patients Receiving Targeted Therapy
PDGF,
PDGF-beta
PDGF receptor Nursing Considerations and Drug Information Targeting Angiogenesis
Pentuzumab (Omnitarg, rhuMab 2C4, investigational) adverse reactions available as class contraindications dosage and administration Hepatocyte Growth Factor (Hgf/C-Met) Receptor Pathway Targets indications mechanism of action Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) nursing issues pharmacokinetics reconstitution and preparation warnings
Peptibodies
Pericytes Antiangiogenic Drug Therapy Invasion and Metastasis Nursing Considerations and Drug Information References (Chapter 3) Targeting Angiogenesis
Perifosine
Periungual tissue, EGFR expression in
Permeability factor
Phenotype, appearance and determination of Epigenetics Invasion and Metastasis
Philadelphia chromosome Application Of The Hallmarks Of Cancer Protein Kinase Inhibitors
Philadelphia chromosome-positive (Ph+) chronic myelocytic leukemia Intracellular Signaling Kinases (E.g., Src, P13k/Akt/Mtor; Mapk; Sonic Hedgehog Pathways) Protein Kinase Signaling Pathways
Phosphatidylserine References (Chapter 4) Targeting Apoptosis
Phosphorylation Application Of The Hallmarks Of Cancer Glossary Hypoxia-Inducible Factor, Mtor, and Angiogenesis Intracellular Signaling Kinases (E.g., Src, P13k/Akt/Mtor; Mapk; Sonic Hedgehog Pathways) Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Protein Kinase Signaling Pathways References (Chapter 2) References (Chapter 3)
PKB,